73 results match your criteria: "is Clinical Pharmacy Specialist[Affiliation]"
AACN Adv Crit Care
June 2024
Jeff Kamta is Clinical Pharmacist, Emergency Medicine, Inova Fairfax Medical Campus, Falls Church, Virginia.
AACN Adv Crit Care
September 2023
Kristin L. Feick is Clinical Pharmacy Specialist-Critical Care, University of Pittsburgh Medical Center Central Pennsylvania Region.
AACN Adv Crit Care
March 2023
Kyle A. Hultz is Clinical Pharmacy Specialist, Department of Pharmacy Services, Memorial Regional Hospital, 3501 Johnson St, Hollywood, FL 33021
AACN Adv Crit Care
December 2022
Sarah Perreault is Clinical Pharmacy Specialist, Bone Marrow Transplant/ CAR T-Cell Therapy, Smilow Cancer Hospital, Yale New Haven Health, New Haven, Connecticut.
AACN Adv Crit Care
June 2022
David Blair is Clinical Pharmacy Specialist-Emergency Medicine, Pharmacy Department, Ascension Genesys Hospital, 1 Genesys Parkway, Grand Blanc, MI 48439
AACN Adv Crit Care
March 2022
Justin J. Delic is Clinical Pharmacy Specialist in Critical Care, Department of Pharmacy, Cooper University Hospital, Camden, New Jersey.
AACN Adv Crit Care
December 2020
Patrick M. Wieruszewski is Clinical Pharmacy Specialist, Cardiothoracic Surgery and Anesthesia Critical Care, Mayo Clinic, Department of Pharmacy, Rochester, Minnesota.
AACN Adv Crit Care
December 2019
Christine R. Parker is Clinical Pharmacy Specialist, Cardiothoracic Intensive Care Unit, Baylor University Medical Center, 3500 Gaston Ave, Dallas, TX 75246, Vivek Kataria is Clinical Pharmacy Specialist, Medical Intensive Care Unit, Baylor University Medical Center, Dallas, Texas.
AACN Adv Crit Care
December 2019
Laura Steffens is Clinical Pharmacist, Emergency Department/Intensive Care Unit, Department of Pharmacy Services, University of Utah Health, Salt Lake City, Utah. Lisa Hayes is Clinical Pharmacy Specialist, Emergency Department/Intensive Care Unit, Department of Pharmacy, Methodist University Hospital, Memphis, Tennessee. Amanda Z. Wiebe is Clinical Pharmacist, Cardiovascular Intensive Care Unit/Surgical Intensive Care Unit, Department of Pharmacy Services, University of Utah Health, 50 N Medical Drive, Salt Lake City, UT 84112
Am J Crit Care
July 2018
Audrey J. Littlefield is clinical pharmacy manager, cardiothoracic intensive care unit, Department of Pharmacy, NewYork-Presbyterian Hospital, Weill Cornell Medical Center, New York, New York. Mojdeh S. Heavner is assistant professor of critical care, Department of Pharmacy Practice and Science, University of Maryland School of Pharmacy, Baltimore, Maryland. Claire C. Eng is clinical pharmacy specialist, critical care, Department of Pharmacy, Memorial Hermann Katy Hospital, Katy, Texas. Dawn A. Cooper is service line educator and Jeanette M. Kurtz is assistant patient service manager, medical intensive care unit and step-down unit, Department of Nursing, Yale New Haven Hospital, New Haven, Connecticut. Jason J. Heavner is chair, Section of Critical Care, University of Maryland Baltimore Washington Medical Center, Glen Burnie, Maryland. Margaret A. Pisani is associate professor and director of the Pulmonary and Critical Care Fellowship Program, Yale University School of Medicine, New Haven, Connecticut.
Background: Many alcohol withdrawal scoring tools are used in hospitalized patients to assess the severity of alcohol withdrawal and guide treatment. The revised Clinical Institute Withdrawal Assessment (CIWA-Ar) and the modified Minnesota Detoxification Scale (mMINDS) are commonly used but have never been correlated.
Objective: To determine the strength of correlation between the CIWA-Ar and mMINDS scoring tools in patients with alcohol withdrawal syndrome.
AACN Adv Crit Care
October 2016
Jaclyn O'Connor is Clinical Pharmacy Specialist, Emergency Medicine, Department of Pharmacy Services, Martin Memorial Hospital, Stuart, Florida. Suprat Saely Wilson is Pharmacy Coordinator, Emergency Medicine Services, Detroit Receiving Hospital, Department of Pharmacy, 1B-UHC, 4201 St Antoine Blvd, Detroit, MI 48201
The incidence of toxic effects of drugs leading to emergency department visits has increased in the United States in the past several years. Most of these patients can be adequately managed by supportive care alone. However, pharmacological antidotes may be necessary, particularly in patients with hemodynamic instability.
View Article and Find Full Text PDFAACN Adv Crit Care
March 2017
Elizabeth L. Huggins and Sarah L. Bloom are Adult-Gerontology Acute Care Nurse Practitioners, Department of Medicine, Vanderbilt University Medical Center (VUMC), 1161 21st Ave S, Suite AA-1214, Nashville, TN 37232-2102 Joanna L. Stollings is Clinical Pharmacy Specialist in the Medical Intensive Care Unit (MICU) and Pharmacist in the ICU Recovery Center, Dept of Pharmaceutical Services, VUMC. Mildred Camp was a patient in the MICU at VUMC. Carla M. Sevin is Assistant Professor, Director of the ICU Recovery Center, Department of Medicine, Division of Allergy, Pulmonary and Critical Care, VUMC. James C. Jackson is Neuropsychologist and Assistant Director of the ICU Recovery Center, Center for Health Services Research, Departments of Medicine and Psychiatry, VUMC, and Geriatric Research, Education and Clinical Center (GRECC) Service, Department of Veterans Affairs, Tennessee Valley Healthcare System, Nashville, Tennessee.
The number of patients surviving critical illness in the United States has increased with advancements in medicine. Post-intensive care syndrome and post-intensive care syndrome-family are terms developed by the Society of Critical Care Medicine in order to address the cognitive, psychological, and physical sequelae emerging in patients and their families after discharge from the intensive care unit. In the United Kingdom and Europe, intensive care unit follow-up clinics have been used to address the complications of post-intensive care syndrome for some time.
View Article and Find Full Text PDFAm J Health Syst Pharm
January 2016
Kristen N. Gardner, Pharm.D., is Clinical Pharmacy Specialist-Behavioral Health, Kaiser Permanente Colorado, Denver; at the time of writing she was Postgraduate Year 2 Psychiatric Pharmacy Resident, Western Missouri Psychiatric Pharmacy Residency Program, Center for Behavioral Medicine, Kansas City, MO. Lauren A. Diefenderfer, Pharm.D., BCPP, is Clinical Pharmacist, Center for Behavioral Medicine. Leigh Anne Nelson, Pharm.D., BCPP, is Associate Professor, University of Missouri-Kansas City (UMKC) School of Pharmacy, Kansas City. Courtney Iuppa, Pharm.D., BCPP, is Clinical Manager; and Ellie Elliott, Pharm.D., BCPP, is Director of Pharmacy, Center for Behavioral Medicine. Kalee Kleinhesselink, Pharm.D., is Clinical Manager; and Debbie Sass, B.S.Pharm., BCPP, is Clinical Pharmacist, Northwest Missouri Psychiatric Rehabilitation Center, St. Joseph. Roger W. Sommi, Pharm.D., BCPP, FCCP, is Associate Dean, UMKC School of Pharmacy at MU, Columbia, and Vice Chair, Division of Pharmacy Practice and Administration, Professor of Pharmacy Practice and Psychiatry, UMKC School of Pharmacy.
Purpose: The cost avoidance and quality of clinical interventions made by postgraduate year 2 (PGY2) psychiatric pharmacy residents are analyzed.
Methods: A retrospective database review of clinical interventions made by PGY2 psychiatric pharmacy residents in two state psychiatric facilities from July 1, 2007 through June 30, 2014, was conducted using a clinical intervention documentation software system. Cost avoidance was calculated by multiplying the mean cost of an adverse drug reaction (ADR) by the probability of an ADR occurring had the intervention not occurred.
Am J Health Syst Pharm
December 2015
Benjamin Hohlfelder, Pharm.D., is Postgraduate Year 2 Critical Care Pharmacy Resident, Department of Pharmacy Services, Brigham and Women's Hospital (BWH), Boston, MA; when this study was conducted, he was Postgraduate Year 1 Pharmacy Practice Resident, Department of Pharmacy Services, BWH. Chad Stashek, Pharm.D., M.S., is Medication Safety Officer; Kevin Anger, Pharm.D., BCPS, is Clinical Pharmacy Specialist; and Paul Szumita, Pharm.D., BCPS, is Clinical Pharmacy Supervisor, BWH.
Purpose: Results of a study to implement targeted interventions to increase the number of documented i.v.-to-oral conversions and to increase cost savings from these documented conversions are reported.
View Article and Find Full Text PDFAm J Health Syst Pharm
December 2015
Brandon R. Shank, Pharm.D., BCOP, is Clinical Pharmacy Specialist, Division of Pharmacy, University of Texas MD Anderson Cancer Center, Houston. Rowena N. Schwartz, Pharm. D., BCOP, is Vice President, Clinical Content and Pharmacy Operations, McKesson Specialty Health, The Woodlands, TX. CAPT (Ret.) Clarence Fortner, USPHS, M.S., resides in Rose Valley, PA. Rebecca S. Finley, Pharm.D., M.S., FASHP, is Dean and Professor, Jefferson College of Pharmacy, Thomas Jefferson University, Philadelphia, PA.
Am J Health Syst Pharm
November 2015
Daniel R. Migliozzi, Pharm.D., BCPS, is Clinical Pharmacy Specialist, Renal Transplant, Department of Pharmacy, Rhode Island Hospital, Providence. Andrew R. Zullo, Pharm.D., is a doctoral student, Department of Health Services, Policy and Practice, Brown University School of Public Health, Providence, and Staff Pharmacist, Department of Pharmacy, Rhode Island Hospital. Christine Collins, B.S.Pharm., M.B.A., is Director, Department of Pharmacy, Rhode Island Hospital. Khaled A. Elsaid, Pharm.D., Ph.D., is Associate Professor, Department of Pharmaceutical Sciences, MCPHS University, Boston, MA.
Purpose: The implementation and outcomes of a program combining electronic home blood pressure monitoring (HBPM) and pharmacist-provided medication therapy management (MTM) services in a renal transplantation clinic are described.
Summary: Patients enrolled in the program were provided with a computer-enabled blood pressure monitor. A dedicated renal transplantation pharmacist was integrated into the renal transplantation team under a collaborative care practice agreement.
Am J Health Syst Pharm
November 2015
Sarah A. Day, Pharm.D., BCPS, is Clinical Pharmacist, Critical Care, Doctors Hospital OhioHealth, Columbus, OH. Michaelia Cucci, Pharm.D., BCPS, is Pharmacy Clinical Specialist-Critical Care, Pharmacy Department, Lakewood Hospital, Lakewood, OH. Molly E. Droege, Pharm.D., BCPS, is Clinical Pharmacy Specialist, Surgery, Orthopedics, and Trauma, UC Health-University of Cincinnati Medical Center, Cincinnati, OH. Jenna M. Holzhausen, Pharm.D., BCPS, is Clinical Pharmacy Specialist, Critical Care, Beaumont Hospital, Royal Oak, MI. Bridgette Kram, Pharm.D., BCPS, is Clinical Pharmacist, Department of Pharmacy, Duke University Medical Center, Durham, NC. Shawn Kram, Pharm.D., BCPS, is Clinical Pharmacist, Medical and Cardiothoracic ICUs, Department of Pharmacy, Duke University Medical Center. Mehrnaz Pajoumand, Pharm.D., is Clinical Specialist, Trauma Critical Care, University of Maryland Medical Center, Baltimore. Christine R. Parker, Pharm.D., BCPS, is Clinical Pharmacy Specialist, Surgical Critical Care, New York-Presbyterian Hospital, Weill Cornell Medical Center, New York, NY. Mona K. Patel, Pharm.D., is Clinical Pharmacy Manager, Surgical Intensive Care Unit, New York-Presbyterian Hospital, Columbia University Medical Center, New York. Gregory J. Peitz, Pharm.D., is Adult Intensive Care Pharmacy Coordinator, Nebraska Medicine, Nebraska Medical Center, Omaha. Alia Poore, Pharm.D., BCPS, is Clinical Pharmacy Specialist-Critical Care, Fairview Hospital, Cleveland, OH. Charles J Turck, Pharm.D., BCPS, is President and CEO, ScientiaCME, LLC, and Scientia Perpetuam, LLC, Highwood, IL. Megan A. Van Berkel, Pharm.D., BCPS, is Clinical Pharmacy Specialist-Emergency Department, Department of Pharmacy, Methodist LeBohneur Healthcare Methodist University Hospital, Memphis, TN. Adrian Wong, Pharm.D., BCPS, is Critical Care Clinical Pharmacist, MountainView Hospital, Las Vegas, NV. Amanda Zomp, Pharm.D., BCPS, is Clinical Pharmacist, Critical Care, Department of Pharmacy Services,
Purpose: Nine recently published articles and one guideline with important implications for critical care pharmacy practice are summarized.
Summary: The Critical Care Pharmacotherapy Literature Update (CCPLU) group includes more than 40 experienced critical care pharmacists across the United States. Group members monitor 29 peer-reviewed journals on an ongoing basis to identify literature relevant to pharmacy practice in the critical care setting.
Am J Health Syst Pharm
October 2015
Justine M. Russell, Pharm. D., BCPS, is Clinical Pharmacy Specialist, Emergency Department; Rebecca L. Nick-Dart, Pharm. D., BCPS, is Clinical Pharmacy Specialist, Internal Medicine; and Brandon D. Nornhold, Pharm. D., BCPS, is Clinical Pharmacy Specialist, Critical Care, Saint Vincent Hospital, Erie, PA.
Purpose: A hospital protocol utilizing automatic dosage adjustments and pharmacist consultations to optimize the use of certain medications in obese patients is described.
Summary: After conducting a literature search focused on medication dosing in obese patients, pharmacists at a large community hospital developed a list of commonly ordered medications appropriate for inclusion in a pharmacy-driven institutional protocol for automatic medication dosage adjustment in adult patients with obesity. Evidence-based recommendations on initial dosing of eight antimicrobials and two anticoagulant agents according to weight and renal function were formulated.
Am J Health Syst Pharm
September 2015
David P. Reardon, Pharm.D., BCPS, is Multispecialty Care Clinical Pharmacist, Department of Pharmacy, Yale-New Haven Hospital, New Haven, CT. Kevin E. Anger, Pharm.D., BCPS, is Clinical Pharmacy Specialist-Critical Care; and Paul M. Szumita, Pharm.D., BCPS, is Clinical Pharmacy Practice Manager, Department of Pharmacy, Brigham and Women's Hospital, Boston, MA.
Purpose: The pathophysiology of pain in critically ill patients, the role of pain assessment in optimal pain management, and pharmacologic and nonpharmacologic strategies for pain prevention and treatment are reviewed.
Summary: There are many short- and long-term consequences of inadequately treated pain, including hyperglycemia, insulin resistance, an increased risk of infection, decreased patient comfort and satisfaction, and the development of chronic pain. Clinicians should have an understanding of the basic physiology of pain and the patient populations that are affected.
Am J Health Syst Pharm
August 2015
Kady Phe, Pharm.D., BCPS, is Infectious Diseases Pharmacotherapy Fellow, Department of Clinical Sciences and Administration, University of Houston College of Pharmacy, Houston, TX. Richard M. Cadle, Pharm.D., BCPS (AQ-ID), FASHP, is Clinical Pharmacy Manager and Residency Program Director, Pharmacy Practice (Postgraduate Year 1) and Infectious Disease (Postgraduate Year 2) Programs, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX. David J. Guervil, Pharm.D., is Clinical Pharmacy Specialist-Infectious Diseases, Department of Pharmacy, Memorial Hermann-Texas Medical Center, Houston. Oscar E. Guzman, Pharm.D., BCPS, is Clinical Director, Infectious Diseases and Critical Care, Cardinal Health, Innovative Delivery Solutions, Houston. Ashley M. Lockwood, Pharm.D., is Postgraduate Year 2 Infectious Diseases Pharmacy Resident, Department of Pharmacy, Houston Methodist Hospital, Houston. Katherine K. Perez, Pharm.D., BCPS, is Clinical Specialist, Infectious Diseases, Departments of Pharmacy and Pathology and Genomic Medicine, Houston Methodist Hospital, and Assistant Professor of Health Sciences and Assistant Clinical Member, Institute for Academic Medicine, Houston Methodist Research Institute, Houston. Nancy N. Vuong, Pharm.D., MBIOT, BCPS, is Infectious Diseases Pharmacotherapy Fellow, Department of Clinical Sciences and Administration, University of Houston College of Pharmacy. Samuel L. Aitken, Pharm.D., BCPS, is Clinical Pharmacy Specialist, Infectious Diseases, Division of Pharmacy, The University of Texas M. D. Anderson Cancer Center, Houston.
Purpose: The most important articles on infectious diseases (ID) pharmacotherapy published in the peer-reviewed literature in 2014, as nominated and selected by panels of pharmacists and others with ID expertise, are summarized.
Summary: Members of the Houston Infectious Diseases Network were asked to nominate articles published in 2014 from prominent peer-reviewed journals that were felt to have a major impact in the field of ID pharmacotherapy. A list of 19 nominated articles on general ID-related topics and 9 articles specifically related to human immunodeficiency virus (HIV) infection or acquired immunodeficiency syndrome (AIDS) was compiled.
Am J Health Syst Pharm
August 2015
Samuel G. Johnson, Pharm.D., BCPS, FCCP, is Clinical Pharmacy Specialist, Applied Pharmacogenomics, Kaiser Permanente Colorado, Denver, and Clinical Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora
Am J Health Syst Pharm
July 2015
Elizabeth Hohner, Pharm.D., is Postgraduate Year 2 Emergency Medicine Resident; Jessica Crow, Pharm.D., BCPS, is Clinical Pharmacy Specialist; and Michael P. Moranville, Pharm.D., BCPS (AQ-Cardiology), is Clinical Pharmacy Specialist, Department of Pharmacy, The Johns Hopkins Hospital, Baltimore, MD.
Purpose: Current strategies for prevention and treatment of "pump thrombosis" associated with the use of left ventricular assist devices (LVADs) are discussed.
Summary: LVADs provide morbidity, mortality, and quality-of-life benefits in patients with advanced heart failure. Since continuous-flow LVADs came into wide use, there have been increased reports of pump thrombosis (clot formation in the LVAD system that can lead to pump dysfunction and clinical complications).
Am J Health Syst Pharm
June 2015
Christopher A. Thomas, Pharm.D., is Clinical Pharmacy Specialist-Pediatric Cardiovascular Intensive Care Unit (ICU), Department of Pharmacy, Riley Hospital for Children at Indiana University Health (IUH), Indianapolis; at the time of writing he was Clinical Pharmacy Specialist-Pediatric Cardiovascular ICU, Department of Pharmacy Services, Phoenix Children's Hospital, Phoenix, AZ. Jennifer L. Morris, Pharm.D., is Clinical Pharmacy Specialist-Pediatric ICU, Department of Pharmacy Services, Texas Children's Hospital, Houston; at the time of writing she was Clinical Pharmacy Specialist-Pediatric ICU, Department of Pharmacy Services, Riley Hospital for Children at IUH. Elizabeth A. Sinclair, Pharm.D., is Clinical Pharmacy Specialist-Pediatric ICU, Department of Pharmacy Services, Texas Children's Hospital, Houston. Richard H. Speicher, M.D., is Medical Director, Pediatric ICU, Division of Pediatric Critical Care, Rainbow Babies and Children's Hospital, Cleveland, OH, and Assistant Professor, Department of Pediatrics, School of Medicine, Case Western Reserve University, Cleveland. Sheikh S. Ahmed, M.D., is Assistant Professor of Clinical Pediatrics, Section of Pediatric Pulmonology, Critical Care and Allergy, Riley Hospital for Children at IUH. Alexandre T. Rotta, M.D., is Chief, Division of Pediatric Critical Care, Rainbow Babies and Children's Hospital, and Professor, Department of Pediatrics, School of Medicine, Case Western Reserve University.
Purpose: The implementation of a diuretic stewardship program in a pediatric cardiovascular intensive care unit (ICU) is described.
Methods: This retrospective study compared the use of i.v.
Am J Health Syst Pharm
June 2015
Zubeir Nurgat, B.Pharm., M.Sc., BCOP, is Manager; Dima Faris, B.Sc.Phm., is Pharmacist; Maher Mominah, B.Sc.Phm., is Specialist, Pharmacy Automation and Support Services; Arris Vibar, B.Sc.Phm., is Pharmacist; and Abdulrazaq Al-Jazairi, Pharm.D., M.B.A., BC PS, is Head, Medical/Critical Care, Pharmaceutical Care Division, King Faisal Specialist Hospital & Research Centre (KFSH&RC), Riyadh, Saudi Arabia. Sheena Ewing, B.Sc., M.Sc., RG N, OCN, is Program Director, Nursing, KFSH&RC. Mohammed Ashour, B.Sc., M.Sc., is Manager, Ambulatory Care Oncology Pharmacy; Shrouq Kamel Qaisi, Pharm.D., is Clinical Pharmacy Specialist, Ambulatory Care; and Sakra Balhareth, Pharm.D., BCPS, BCAC P, is Clinical Pharmacy Specialist, Drug Information Center, Pharmaceutical Care Division, KFSH&RC. Ahmed Al-Jedai, Pharm.D., M.B.A., BCPS, is Director, Pharmaceutical Care Division, and Associate Professor, College of Medicine, Alfaisal University, KFSH&RC.
Purpose: Results of a performance evaluation of an automated system for compounding antineoplastic preparations are reported.
Methods: Three years after the pharmacy department of a hospital in Saudi Arabia installed an i.v.
Am J Health Syst Pharm
June 2015
Mathew C. Jones, Pharm.D., BCPS, is Clinical Pharmacy Specialist, Neurointensive Care, Department of Pharmacy, Henry Ford Hospital, Detroit, MI. Tracey Lasak-Myall, Pharm.D., BCPS, ATC, is Associate Medical Scientific Liaison, Allergan, Inc., Irvine, CA. Tamer M. Abdelhak, M.D., is Director of Neurocritical Care, Southern Illinois University School of Medicine, Springfield. Panayiotis N. Varelas, M.D., Ph.D., is Director, Neurosciences Intensive Care Unit, Henry Ford Hospital. At the time of writing, Drs. Lasak-Myall, Abdelhak, and Varelas worked at Henry Ford Hospital.
Purpose: Successful use of i.v. indomethacin for urgent management of elevated intracranial pressure (ICP) due to acute liver failure is reported.
View Article and Find Full Text PDF